药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alphameprodine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Gilteritinib.
Alphameprodine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Gilteritinib.
Alphameprodine
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Gilteritinib.
Alphameprodine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Dexverapamil.
Alphameprodine
Penfluridol
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Penfluridol.
Alphameprodine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Dexchlorpheniramine.
Alphameprodine
Lorcainide
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Lorcainide.
Alphameprodine
Bunaftine
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Bunaftine.
Alphameprodine
Nizofenone
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Nizofenone.
Alphameprodine
Otilonium
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Otilonium.
Alphameprodine
Sultopride
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Sultopride.
Alphameprodine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Sitafloxacin.
Alphameprodine
Oxatomide
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Oxatomide.
Alphameprodine
Abexinostat
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Abexinostat.
Alphameprodine
Mizolastine
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Mizolastine.
Alphameprodine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Ricolinostat.
Alphameprodine
Simendan
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Simendan.
Alphameprodine
CUDC-101
The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with CUDC-101.
Alphameprodine
Entinostat
The risk or severity of QTc prolongation can be increased when Entinostat is combined with Gilteritinib.
Alphameprodine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Gilteritinib.